Type your tag names separated by a space and hit enter

Anti-Saccharomyces cerevisiae (ASCA) and perinuclear antineutrophil cytoplasmic antibodies (pANCA) in the diagnosis of Crohn's disease and ulcerative colitis

Anti-Saccharomyces cerevisiae (ASCA) and perinuclear antineutrophil cytoplasmic antibodies (pANCA) in the diagnosis of Crohn's disease and ulcerative colitis is a topic covered in the Evidence-Based Medicine Guidelines.

To view the entire topic, please sign in or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

20 mcg versus >20 mcg estrogen combined oral contraceptives for contraception

"Snowball fingers" - Image

Botulinum toxin for the treatment of strabismus: Cochrane systematic review

ACC/AHA: Fewer patients require prophylaxis for endocarditis

Citation

"Anti-Saccharomyces Cerevisiae (ASCA) and Perinuclear Antineutrophil Cytoplasmic Antibodies (pANCA) in the Diagnosis of Crohn's Disease and Ulcerative Colitis." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/450864/all/Anti_Saccharomyces_cerevisiae__ASCA__and_perinuclear_antineutrophil_cytoplasmic_antibodies__pANCA__in_the_diagnosis_of_Crohn's_disease_and_ulcerative_colitis.

Anti-Saccharomyces cerevisiae (ASCA) and perinuclear antineutrophil cytoplasmic antibodies (pANCA) in the diagnosis of Crohn's disease and ulcerative colitis. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/450864/all/Anti_Saccharomyces_cerevisiae__ASCA__and_perinuclear_antineutrophil_cytoplasmic_antibodies__pANCA__in_the_diagnosis_of_Crohn's_disease_and_ulcerative_colitis. Accessed February 16, 2019.

Anti-Saccharomyces cerevisiae (ASCA) and perinuclear antineutrophil cytoplasmic antibodies (pANCA) in the diagnosis of Crohn's disease and ulcerative colitis. (2019). In Evidence-Based Medicine Guidelines. Available from https://evidence.unboundmedicine.com/evidence/view/EBMG/450864/all/Anti_Saccharomyces_cerevisiae__ASCA__and_perinuclear_antineutrophil_cytoplasmic_antibodies__pANCA__in_the_diagnosis_of_Crohn's_disease_and_ulcerative_colitis

Anti-Saccharomyces Cerevisiae (ASCA) and Perinuclear Antineutrophil Cytoplasmic Antibodies (pANCA) in the Diagnosis of Crohn's Disease and Ulcerative Colitis [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2019 February 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/450864/all/Anti_Saccharomyces_cerevisiae__ASCA__and_perinuclear_antineutrophil_cytoplasmic_antibodies__pANCA__in_the_diagnosis_of_Crohn's_disease_and_ulcerative_colitis

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case

TY - ELEC T1 - Anti-Saccharomyces cerevisiae (ASCA) and perinuclear antineutrophil cytoplasmic antibodies (pANCA) in the diagnosis of Crohn's disease and ulcerative colitis ID - 450864 BT - Evidence-Based Medicine Guidelines UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/450864/all/Anti_Saccharomyces_cerevisiae__ASCA__and_perinuclear_antineutrophil_cytoplasmic_antibodies__pANCA__in_the_diagnosis_of_Crohn's_disease_and_ulcerative_colitis PB - Duodecim Medical Publications Limited DB - Evidence Central DP - Unbound Medicine ER -